Gloria Hopkins Sura, M.D.
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Gloria Hopkins Sura
Dr. Sura is board-certified by the American Board of Pathology in Anatomic and Clinical Pathology, Cytopathology, and Molecular Genetic Pathology. She completed her pathology residency at Louisiana State University Health Sciences Center in New Orleans, followed by fellowships in Cytopathology and Molecular Genetic Pathology at Houston Methodist Hospital in the Texas Medical Center.
As a practicing clinical pathologist, Dr. Sura is dedicated to advancing diagnostic laboratory medicine and translational research. Her work centers on optimizing molecular testing strategies for minimally invasive specimens and studying the influence of pre-analytical factors on RNA sequencing quality in oncologic cytology. She is also focused on enhancing cytopathology laboratory workflows, including validation of non-traditional specimen types and development of rapid molecular testing approaches.
Dr. Sura serves as the Executive Officer of the Translational Research Program for the Alliance for Clinical Trials in Oncology, where she helps to guide the development, execution, and integration of molecularly driven oncology trials and biomarker strategies.
Present Title & Affiliation
Primary Appointment
Assistant Professor, Anatomic Pathology, Section of Cytopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Anatomic Pathology, Section of the Molecular Diagnostic Laboratory, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2017 | Poznan University of Medical Sciences, Poznan, PL, MD |
| 2013 | University of Hawai'i at Manoa, Honolulu, Hawaii, US, Biology, BA (Summa Cum Laude) |
Postgraduate Training
| 2022-2023 | Clinical Fellowship, Chief Fellow, Molecular Genetic Pathology, Houston Methodist, Houston, Texas |
| 2021-2022 | Clinical Fellowship, Cytopathology, Houston Methodist, Houston, Texas |
| 2017-2021 | Clinical Residency, Chief Resident, Anatomic and Clinical Pathology, Louisiana State University Health Sciences Center New Orleans, New Orleans, Louisiana |
Licenses & Certifications
| 2023 | Molecular Genetic Pathology |
| 2022 | Cytopathology |
| 2021 | Anatomic and Clinical Pathology |
| 2021 | Texas Medical License |
Experience & Service
Other Professional Positions
Executive Officer of the Translational Research Program, The Alliance for Clinical Trials in Oncology, 2025 - Present
Intramural Institutional Committee Activities
Co-Director, Project ECHO® (Extension for Community Healthcare Outcomes) Indonesia - Pathology Program, The University of Texas MD Anderson Cancer Center, 2026 - Present
Officer, Patient Safety and Quality Officer for the Molecular Diagnostic Laboratory Solid Tumor Section, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Clinical Genomics and Biomarker Council, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Genomic Testing Priority: Organization and Infrastructure Growth, The University of Texas MD Anderson Cancer Center, 2024 - 2025
Member, Program Evaluation Committee: Cytopathology Fellowship Program, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Clinical Competency Committee: Cytopathology Fellowship, The University of Texas MD Anderson Cancer Center, 2023 - Present
Extramural Institutional Committee Activities
Member Pathologist, National Clinical Trials Network Core Correlative Sciences Committee (NCTN-CCSC), National Institutes of Health, 2026 - Present
Member, Working Group: Blood-Based Assays, National Cancer Institute, 2026 - Present
Social Media Advisor, Cancer Cytopathology, Cancer Cytopathology, 2026 - Present
Member, Future Pathology Champions, College of American Pathologists, 2025 - Present
Member, Conflict of Interest Committee, The Alliance for Clinical Trials in Oncology, 2025 - Present
Member, Pathology and Laboratory Medicine Committee, The Alliance for Clinical Trials in Oncology, 2024 - Present
Texas Delegate, House of Delegates, College of American Pathologists, 2023 - Present
Executive Officer, Translational Research Program, The Alliance for Clinical Trials in Oncology, 2023 - Present
Member, Integrating Biospecimen Science Approaches into Clinical Assay Development - Steering Committee for PAR 25-325, previously: PAR 22-049, PAR 18-947, PAR 16-166, National Cancer Institute, 2023 - Present
Lead, Working Group: Best Practices for RNA Sequencing from Cytology and Small Biopsy Specimens, National Cancer Institute, 2023 - 2026
Junior Member, Council on Accreditation, College of American Pathologists, 2019 - 2021
Editorial Activities
Editorial Board Member, Cytopathology: official journal of the British Society for Clinical Cytology, 2023 - Present
Honors & Awards
| 2026 - Present | Spotlight: Rising Stars in Cytology, Cancer Cytopathology |
| 2026 | Mentored Trainee Research Award, Division of Pathology and Laboratory Medicine Research Retreat, The University of Texas MD Anderson Cancer Center |
| 2026 | Mentored Trainee Research Award, Division of Pathology and Laboratory Medicine Research Retreat, The University of Texas MD Anderson Cancer Center |
| 2025 | Reviewer of the Month, Translational Lung Cancer Research |
| 2025 | Reviewer of the Month, Gland Surgery |
| 2023 | Microscopic Photograph Award, Houston Methodist Department of Pathology and Genomic Medicine |
| 2023 | Research Award, Papanicolaou Society of Cytopathology |
| 2019 | Best Microscopic Photo Award - Annual Photo Contest, Graduate Research in Pathology Education (GRIPE) |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. The Expanding Role of Molecular and Biomarker Applications in Cytopathology. Invited. Cancer Biomarkers Conference. Houston, Texas, US.
- 2026. Molecular Pathology: Reading the Code of Cancer. Invited. ONCORE MD Anderson Youth Summer Program. Houston, Texas, US.
- 2026. Cytology Quality Improvement Review. Conference. Quality Improvement Conference. Houston, Texas, US.
- 2025. Important Biomarkers in Cytopathology. Invited. Houston, TX, US.
- 2025. Estimating Neoplastic Cellularity. Invited. Houston, Texas, US.
- 2024. Tips for Faculty Interviews: Expert Panel Q&A Session. Panelist. Houston, TX, US.
- 2024. Ultra-Rapid Molecular Testing of Cytology Fine Needle Aspiration Specimens. Invited. Neurointerventional Radiology Ultrasound (NIRUS) Emphasis. Houston, Texas, US.
- 2024. Ultra-Rapid, Cost-Effective Targeted Cytomolecular Diagnostics. Poster. Department of Pathology and Laboratory Medicine Annual Research Day 2024. Houston, Texas, US.
National Presentations
- 2026. Biomarker Selection for Clinical Trials: A Molecular Pathologist's Perspective. Invited. Alliance Spring Group Meeting. Chicago, Illinois, US.
- 2026. Molecular Testing in Cytopathology, Pre-Analytics. Invited. Cytopathology and Small Biopsy Updates. Houston, Texas, US.
- 2025. Updates on RNA Sequencing from Cytopathology and Small Biopsy Specimens. Invited. 2025 Steering Committee: Integrating Biospecimen Science Approaches into Clinical Assay Development (PAR 25-325). Shady Grove, Maryland, US.
- 2025. Validation of the Idylla GeneFusion Assay for Ultrarapid Detection of NTRK Fusions in Solid Tumors. Poster. The Association for Molecular Pathology 2025 Annual Meeting & Expo. Boston, MA, US.
- 2025. From Smear to Sequence: The Critical Role of Preanalytical Factors in Validating Cytology Specimens for Hybrid Capture Next-Generation Sequencing. Poster. The Association for Molecular Pathology 2025 Annual Meeting & Expo. Boston, MA, US.
- 2025. Translational Molecular Research in Cytopathology Specimens. Invited. Pathology and Laboratory Medicine Committee Meeting for the Alliance for Clinical Trials in Oncology, US.
- 2025. Optimizing and Troubleshooting Cytology Preparations for Hybridization Capture-Based Next-Generation Sequencing. Poster. 16th Annual Meeting of the Cancer Genomics Consortium. Houston, Texas, US.
- 2025. Unraveling the Nexus: Tumor Mutational Burden, PD-L1 Expression and Oncogene Specific Alterations in Cytology Specimens of Non-Small Cell Lung Cancer. Poster. United States and Canadian Academy of Pathology 2025 Annual Meeting. Boston, MA, US.
- 2025. From Discard to Discovery: Rapid KRAS and EGFR Mutation Detection in Lung Cancer Using Cytology Supernatants. Poster. United States and Canadian Academy of Pathology 2025 Annual Meeting. Boston, MA, US.
- 2024. Integrating Biospecimen Science into the Development Of RNA-Based Clinical Assays for Patients with Metastatic Breast Cancer. Invited. 2024 Annual Steering Committee Meeting for PAR 16-166/18-947/22-049 Integrating Biospecimen Science Approaches into Clinical Assay Development. Shady Grove, MD, US.
- 2024. RAF Family Fusions in Thyroid Carcinomas: Clinicopathological Analysis of 16 Patients. Poster. American Thyroid Association Annual Meeting 2024. Chicago, IL, US.
- 2024. Pathology for the Clinical Research Professional: Reading a Molecular Report & Pathologic versus Clinical Staging. Invited. Alliance for Clinical Trials in Oncology Spring 2024 Group Meeting. Chicago, Illinois, US.
- 2024. Comparison of Ficoll-Hypaque Enrichment versus the CytoLyt Method for Clearing Blood from Malignant Effusions: Effects on RNA Quality, Sequencing, and Analysis. Poster. United States and Canadian Academy of Pathology's 113th Annual Meeting 2024. Baltimore, Maryland, US.
- 2024. Molecular testing opportunities on cytology effusion specimens: the pre-analytic effects of various body fluid cytology preparation methods on RNA extraction quality and targeted sequencing. Invited. Cyto Ejournal, US.
- 2023. Integrating Biospecimen Science into the Development of RNA-Based Clinical Assays for Patients with Metastatic Breast Cancer. Invited. 2023 Annual Steering Committee Meeting for PAR 16-166/18-947/22-049 Integrating Biospecimen Science Approaches into Clinical Assay Development. Shady Grove, Maryland, US.
- 2023. Precision Medicine for Salivary Gland Tumor Patients: Experience Using a Large Next-Generation Sequencing-Based RNA Assay to Detect Cancer Associated Gene Alterations at a Multi-Hospital Institution. Poster. The Association for Molecular Pathology 2023 Annual Meeting & Expo. Salt Lake City, UT, US.
- 2023. Molecular Testing Opportunities on Cytology Effusion Specimens. Invited. American Society of Cytopathology eJournal. Houston, Texas, US.
- 2023. Biomarker Testing in Non-Small Cell Lung Cancer. Conference. Cytology Conference. Houston, Texas, US.
- 2023. Utility of Whole Slide Imaging for Evaluation of Thyroid Fine Needle Aspiration: A Multi-Reader Prospective Study. Poster. College of American Pathologists 2023 Annual Meeting. New Orleans, LA, US.
- 2023. Pre-Analytical Effects on Targeted and Whole Transcriptome RNA Sequencing Analysis in Cytology: The Effects of Prolonged Time in Storage of Effusion Specimens Prior to Preservation. Poster. United States and Canadian Academy of Pathology 2023 Annual Meeting. New Orleans, LA, US.
- 2022. Outcomes of Molecular Testing on Thyroid Fine Needle Aspiration Cytology with Histologic Correlation: A Multicenter Retrospective Study on the Management of Indeterminate Thyroid Nodules. Poster. Association for Molecular Pathology 2022 Annual Meeting & Expo. Phoenix, AZ, US.
- 2022. Assessing the Quality of Cytopathology Whole Slide Imaging for Education from Archived Slides. Poster. College of American Pathologists 2022 Annual Meeting. New Orleans, LA, US.
- 2019. Schistosomiasis Associated with Secondary Amyloidosis. Poster. College of American Pathologists 2019 Annual Meeting. Orlando, FL, US.
- 2019. Optimizing Cytology Cell Block Preparations to Advance Diagnosistic Patient Care. Poster. Quality Improvement & Patient Safety Forum. New Orleans, LA, US.
- 2019. Concordance Analysis Between Prostate Imaging: Reporting and Data System (PI-RADSv2) and Prostatic Histologic Findings. Poster. United States and Canadian Academy of Pathology 2019 Annual Meeting. National Harbor, MD, US.
- 2019. Heterotopic Ossification of the Mesentery: Pathologic Findings from Autopsy. Poster. United States and Canadian Academy of Pathology 2019 Annual Meeting. National Harbor, MD, US.
- 2018. Hyphae in Invasive Coccidioides. Poster. College of American Pathologists 2018 Annual Meeting. Chicago, IL, US.
International Presentations
- 2026. Molecular Testing of Cytopathology Specimens. Invited. 56th Annual Conference of the Indian Academy of Cytologists (CYTOCON 2026). Lucknow, IN.
- 2026. Molecular Aspects in Pediatric Tumors Applied to Cytopathology. Invited. 46th European Congress of Cytology. Antwerp, BE.
- 2026. Cytopathology Case-Based Learning: A Day in the FNA Clinic. Invited. Project ECHO® (Extension for Community Healthcare Outcomes) Indonesia - Pathology Program MD Anderson Cancer Center. Houston/Jakarta, ID.
- 2025. Molecular to the rescue: How ancillary molecular testing resolved a cytologic dilemma in lung cytology. Invited. 22nd International Congress of Cytology. Florence, IT.
- 2025. Molecular Diagnostics in the Evaluation of Thyroid Nodules and Cytology. Invited. Project ECHO® (Extension for Community Healthcare Outcomes) Indonesia Pathology. Houston/Jakarta.
- 2025. RNA Sequencing from Small Biopsy Specimens: Challenges and Best Practices. Poster. International Society of Biological and Environmental Repositories (ISBER) 2025 Annual Meeting. Montreal, CA.
- 2024. Same-Day Molecular Testing for Targetable Mutations in Solid Tumor Cytopathology - The Next Frontier of the Rapid On-Site Evaluation and Optimizing Small Biopsy Workflow with Biocartis Idylla. Invited. Association of Molecular Pathology Annual Meeting 2024. Vancouver, CA.
- 2024. Assessment of BRAF Fusions in 177,227 Thyroid Nodules by Exome-Enriched RNA-Seq Testing. Poster. Association of Molecular Pathology Annual Meeting 2024. Vancouver, CA.
- 2024. Same-Day Molecular Testing for Targetable Mutations in Solid Tumor Cytopathology - The Next Frontier of the Rapid On-Site Evaluation. Poster. Association of Molecular Pathology Annual Meeting 2024. Vancouver, CA.
- 2024. Molecular Session: Lymph Node. Invited. 45th European Congress of Cytology 2024. Leipzig, DE.
- 2024. Joint session by the Journal of the American Society of Cytopathology (JASC) and the Cytopathology: Highlighted Molecular Cytopathology Papers from 2023. Invited. 45th European Congress of Cytology 2024. Leipzig, DE.
Grant & Contract Support
| Date: | 2025 - Present |
| Title: | Executive Officer of the Translational Research Program |
| Funding Source: | Alliance for Clinical Trials in Oncology |
| Role: | PI |
| Date: | 2024 - Present |
| Title: | Study to investigate the capability of the Idylla™ GeneFusion Assay in detecting NTRK1/2/3 fusion in a pancancer setting |
| Funding Source: | Biocartis |
| Role: | PI |
| Date: | 2023 - 2024 |
| Title: | Ultra-Rapid, Cost-Effective Targeted Cytomolecular Diagnostics for Lung Cancer Patient |
| Funding Source: | Department of Pathology, Departmental Mentorship Committee |
| Role: | PI |
| Date: | 2022 - 2023 |
| Title: | Analysis of Cancer-Associated Gene Rearrangements in Solid Organ Tumors |
| Funding Source: | Houston Methodist Department of Pathology and Genomic Medicine |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Atwell H, Roy-Chowdhuri S, Seyedjafari R, Hill H, Du L, Zhang J, Koci C, Palmer A, Mendoza Y, Ma S, Hu Y, Flores N, Bryan J, Chen H, Luthra R, Ballester L, Patel K, Kulkarni S, Sura GH. The Critical Role of Preanalytical Factors in Validating Cytology Specimens for Hybrid-Capture Next-Generation Sequencing: From Smear to Sequence The Journal of Molecular Diagnostics. J Mol Diagn. e-Pub 2026.
- Sura GH, Arjuna S, Maher MH, Duose D, Bollen L, Hebert D, Serifert F, Van Dorst B, Janssens JCA, Caffes P, Lo YC. Validation of NTRK Fusion Detection Using an Ultrarapid, Fully Automated Cartridge-based PCR Assay. J Mol Diagn. e-Pub 2026.
- Roy-Chowdhuri S, Agarwal N, Gulraiz F, Ballester L, Chen H, Kanagal-Shamanna R, Kulkarni S, Patel K, Sura GH, Zhang NJ, Luthra R. Analytical Validation of a Rapid Next Generation Sequencing-Based Liquid Biopsy Assay Using Fine Needle Aspiration Supernatants for Clinical Use. J Am Soc Cytopathol, 2026.
- Htun NN, Morris BB, Roy-Chowdhuri S, Sura GH. Decoverslipping of Archival Cytology Aspirate Smears for Ancillary Studies: A Review of Methods and Institutional Experience with Freezer-Based Techniques. Cytopathol. e-Pub 2026.
- Parham M, Geetha SD, Ost DE, Lavu S, Sura GH. From Discard to Discovery: Leveraging Residual Cytology Fine Needle Aspiration Supernatants for Rapid EGFR and KRAS Mutation Detection in Lung Cancer Available. Acta Cytol, 2026. e-Pub 2026. PMID: 42068558.
- Dai M, San Lucas FA, Alvarez H, Ballester L, Chen H, Patel KP, Rashid A, Rao S, Routbort MJ, Sura G, Sweeney K, Toruner G, Wei P, Yang R, Dang H, Luthra R, Roy-Chowdhuri S. Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimens. Cancer Cytopathol 134(4), 2026. e-Pub 2026. PMID: 41891376.
- Chen, YW, Xiu, J, Poorman, K, Ryan, CJ, Gilg, B, Oberley, MJ, Sura, GH, Sledge, GW, Zhao, SG, Tan, A, Beltran, H, McKay, R. Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer. JCO Precision Oncology 10, 2026. e-Pub 2026. PMID: 41785440.
- Ahmed MS, Klippel-Almaraz D, Amin SE, Sura GH, Kundu UR, Yu W, Stewart JM, Gan Q, Krishnamurthy S. Utility of whole-slide imaging for rapid evaluation of thyroid FNA: A multireader prospective study. Cancer Cytopathol 133(9), 2025. e-Pub 2025. PMID: 40889104.
- Iorgulescu JB, Yang RK, Chowdhuri SR, Sura GH. Same-day molecular testing for targetable mutations in solid tumor cytopathology-The next frontier of the rapid on-site evaluation. Cancer Cytopathol 133(1):e22930, 2025. e-Pub 2025. PMID: 39746874.
- Sura GH, Tran K, Trevarton AJ, Marczyk M, Fu C, Du L, Qu J, Lau R, Tasto A, Gould RE, Tinnirello A, Sinn BV, Pusztai L, Hatzis C, Symmans WF. Comparative analysis of Ficoll-Hypaque and CytoLyt techniques for blood removal in breast cancer malignant effusions: effects on RNA quality and sequencing outcomes. J Am Soc Cytopathol 14(2):91-101, 2024. e-Pub 2024. PMID: 39668068.
- Sura, GH, Hsu, J, Mody, DR, Thomas, JS. Precision medicine for patients with salivary gland neoplasms. CytoJournal 21(1), 2024. e-Pub 2024. PMID: 39737124.
- Sura GH, Thrall MJ, Rogers J, Hodjat P, Christensen P, Cubb T, Khadra HS, Khadra HS, Thomas JS, Jacobi EM. A retrospective analysis of molecular testing in cytologically indeterminate thyroid nodules with histologic correlation: Experience at a heterogenous multihospital system. Diagn Cytopathol 52(2):82-92, 2023. e-Pub 2023. PMID: 37950548.
- Sura GH, Tran K, Fu C, Du L, Marczyk M, Gould RE, Chen E, Tasto AM, Tinnirello AA, Symmans WF. Pre-analytical effects on whole transcriptome and targeted RNA sequencing analysis in cytology: The effects of prolonged time in storage of effusion specimens prior to preservation. Cytopathol 34(6):551-561, 2023. e-Pub 2023. PMID: 37712171.
- Sura GH, Tran K, Fu C, Du L, Marczyk M, Martinez Y, Tinnirello AA, Gould RE, Lau R, Symmans WF. Molecular testing opportunities on cytology effusion specimens: the pre-analytic effects of various body fluid cytology preparation methods on RNA extraction quality and targeted sequencing. J Am Soc Cytopathol 12(1):10-19, 2023. e-Pub 2023. PMID: 36270909.
- Sura GH, Khazai L. Gastric glomus tumor on fine needle aspiration. Diagn Cytopathol 50(12):581-582, 2022. e-Pub 2022. PMID: 36101971.
- Sura GH, Doan JV, Thrall MJ. Assessing the quality of cytopathology whole slide imaging for education from archived cases. J Am Soc Cytopathol 11(5):313-319, 2022. e-Pub 2022. PMID: 35780060.
- Yousefi E, Sura GH, Somma J. The gray zone of thyroid nodules: Using a nomogram to provide malignancy risk assessment and guide patient management. Cancer Med 10(8):2723-2731, 2021. e-Pub 2021. PMID: 33763983.
- Ibrahim, M, Sweeney, P, Alapati, T, Hajja, Y, Sura, GH, Subbiah, S. High CD4 count and bone marrow infiltration in untreated hiv-associated Kaposi sarcoma. Current Problems in Cancer: Case Reports 3, 2021. e-Pub 2021.
- Sura, GH, LeRoy, M. Schistosomiasis associated with secondary amyloidosis. Human Pathology: Case Reports 20, 2020. e-Pub 2020.
Invited Articles
- Sura GH. Specimen Considerations, Clinical Utilization, and Test Reporting. Surg Pathol Clin, 2026. e-Pub 2026.
- Sura GH. Incorporation of DNA methylation profiling into the cytopathology laboratory. Cancer Cytopathol 132(9):543-546, 2024. e-Pub 2024. PMID: 38488294.
Review Articles
- Sura, GH. Specimen Considerations, Clinical Utilization, and Test Reporting. Surgical Pathology Clinics 19(2):175-184, 2026. e-Pub 2026. PMID: 42091267.
- Sura GH, Engel KB, Greytak SR, Gaston SM, McKillip KD, Rao A, Guan P, Symmans WF, Clark R, Arcila M, Ghatak S, Bomsztyk K, Agrawal L. Pre-analytical Best Practices for RNA Sequencing from Small Biopsies and Cytologic Specimens. Mol Diagn Ther, 2026. e-Pub 2026. PMID: 41831145.
- Sura GH. Targetable Molecular Profiles in Salivary Duct Carcinoma: A Review and Case Study of Molecular Diagnostic and Therapeutic Implications. Diagn Cytopathol, 2025. e-Pub 2025. PMID: 40613550.
- Ijaz K, Sura GH. Identifying HHV-6 Induced Cytopathic Effects in Bronchoalveolar Lavage Fluid Preparations to Enhance Care in Immunocompromised Patients. Diagn Cytopathol 53(7):357-360, 2025. e-Pub 2025. PMID: 40317688.
- Herman, M, Schukow, CP, Tatarian, A, El-Zaatari, ZM, Sura, GH, Bui, MM. #PathArt: from glass slide to canvas; with a mission of enlightening the burdens of life. Academic Pathology 12(1), 2025. e-Pub 2025. PMID: 39981158.
- Sura, GH, Jackson, NR, Yodzis, S, Fox, SE. Heterotopic Ossification of the Mesentery. AJSP: Reviews and Reports 26(4):E1-E5, 2021. e-Pub 2021.
Web Publications
- Sura GH, Thomas J. Salivary gland neoplasms: the role of molecular testing in optimizing patient care, 2025.
- Sura GH, Thomas JS. Molecular Biomarkers in Salivary Gland Neoplasms, 2025.
- Sura GH. A Stunning Smear: A look into a colourful cervical pap test, 2023.
Patient Reviews
CV information above last modified August 29, 2026